pillbase.ru

Nateglinide

Active substance: nateglinide

TABLET · NATEGLINIDE 60 mg/1

United StatesActive

Marketing holder: Dr. Reddy's Laboratories Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Trazec
    nateglinide
    EMEA/H/C/000383
    Novartis Europharm Ltd.
  • Starlix
    nateglinide
    EMEA/H/C/000335
    Novartis Europharm Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4a87-7126-b262-f19b07ef6ab1,01a1208d-3656-7863-8673-f0d55b3158fc,01a1208d-acb9-70d3-b846-511c6f95220e,01a1208e-0731-798c-b766-ae29d171e51e,01a1208e-6793-765d-878e-d38f62c0a78d;count=18 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
55111-328
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 55111-328 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 55111-328 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 55111-328 · Verified 2026-10-09 · open in source